Ventilator-Associated PneumoniaRichard G. Wunderink, Richard D. Wunderink, Jordi Rello Springer Science & Business Media, 31 ott 2001 - 179 pagine Ventilator-associated pneumonia (VAP) continues to be one of the greatest challenges to critical care practitioners and one of the greatest threats to the survival of our patients. The choice of this topic for an issue of the PERSPECTIVES IN CRITICAL CARE INFECTIOUS DISEASES Series is therefore quite appropriate. Despite its importance, many areas of the management of ventilator-associated pneumonia remain controversial. We therefore are pleased to include contributions from experts and investigators offering different perspectives on some of these controversial areas. |
Sommario
DIAGNOSIS OF PNEUMONIA | 1 |
DIAGNOSIS OF VENTILATORASSOCIATED PNEUMONIA | 17 |
PREVENTION OF PNEUMONIA IN MECHANICALLY VENTILATED PATIENTS | 29 |
IS PREVENTION OF VENTILATOR ASSOCIATED PNEUMONIA COST EFFECTIVE? | 45 |
ROLE OF THE OROPHARYNX AND DIGESTIVE TRACT IN THE PATHOGENESIS OF VENTILATORASSOCIATED PNEUMONIA | 61 |
TREATMENT OF VENTILATORASSOCIATED PNEUMONIA | 77 |
Altre edizioni - Visualizza tutto
Parole e frasi comuni
Acinetobacter baumannii airway aminoglycosides Ann Intern antibiotic resistance antibiotic therapy antibiotic-resistant antimicrobial agents antimicrobial resistance antimicrobial therapy antimicrobial treatment associated pneumonia attributable mortality B-lactamases bacteremia bacteria bronchoalveolar lavage bronchoscopic carbapenems caused ceftazidime cephalosporins Chastre Chest ciprofloxacin Clin Infect clinical critically ill patients development of VAP diagnosis drug effect empiric therapy Enterobacter Enterobacteriaceae enterococci ESBLs evaluated Fagon JY flora gastric colonization gram-negative gram-negative bacilli hospital imipenem increased Infect Control initial intensive care unit intubated invasive isolates Klebsiella Kollef MH lower respiratory tract lung maltophilia mechanical ventilation mechanically ventilated patients methicillin-resistant microbiologic microorganisms mortality of VAP MRSA multiresistant Niederman nosocomial infections nosocomial pneumonia organisms oropharyngeal pathogens patients receiving plasmids prevention prior antibiotic prophylaxis protected specimen brush Pseudomonas aeruginosa quantitative cultures randomized rates reduce regimen Rello Respir Crit Rev Respir risk factors samples secretions specific Staphylococcus aureus subglottic susceptibility suspected techniques Torres vancomycin ventilator-associated pneumonia Wunderink